Anti-Adhesion Products Market Analysis | China | 2016-2022 | MedCore

Anti-Adhesion Products Market Analysis | China | 2016-2022 | MedCore


The anti-adhesion market, also referred to as the adhesion prevention market, includes products aimed at
minimizing surgical adhesions. Surgical adhesions are fibrous bands that form between tissues and organs,
often as a result of injury during surgery. These adhesions can be formed during any type of surgery,
including gynecological, abdominal, orthopedic, cardiac and neurological procedures.

  • Year: 2016
  • Scope: 2012-2022
  • Region: China
  • Published Date: 4/1/2016
  • Pages: 46
  • Type: MedCore

Adhesions are often thought of as internal scar tissue and are a side effect of the body’s natural healing process. For example, up to 93% of patients who undergo intra-abdominal surgery develop adhesions. The majority of adhesions are asymptomatic; however, approximately 5% of adhesions result in severe symptoms such as pain, small bowel obstruction (SBO), range of motion restriction and/or infertility. While only 5% of adhesions result in symptoms severe enough to require further treatment, as many as 30% are thought to cause low level discomfort that is tolerated by the patient. Adhesions are believed to be responsible for approximately 65% of all SBO, 35% of chronic pelvic pain and 20% of infertility diagnoses. There are a number of different methods that surgeons use to reduce the incidence of adhesions. The most effective way is to perform laparoscopic procedures whenever possible, as they carry a much lower risk of symptomatic adhesion formation. In addition, surgeons attempt to minimize tissue necrosis, providing meticulous hemostasis, liberally irrigating the abdominal cavity and using non-reactive suture materials. In some situations, drugs that inhibit the inflammatory response, such as corticosteroids, non-steroidal anti-inflammatory, pentoxifylline and calcium channel blockers have been used. However, the most effective method of reducing adhesions has been determined to be the use of adhesion barriers. The first of currently used products entered the market in 1989 and was made out of oxidized regenerated cellulose (ORC). It is absorbed within four weeks of application. Seprafilm® by Genzyme consists of sodium hyaluronate and carboxymethylcellulose, forming a film that becomes a hydrated gel 24 to 48 hours after placement.

The "Chinese Market Report Suite for Wound and Tissue Management 2016 - MedSuite" includes analysis on the following companies currently active in this market:
3H Medical
3L Medical
Applied Medical
B.Braun (Aesculap)
BSN Medical
Changzhou Lookmed Medical Instrument Co Ltd
Chengdu Baier Maidike Medical Technology
David Medical
Domestic Chinese Manufacturers
Elite Medline
Guangxi North Health Pharmaceutical
Guangzhou Hong Jian Bio-Medical Products and Technology
Haida Medical
Hangzhou Singclean Medical Products
Hangzhou Xiehe Medical Supplies
Hualan Bio
Huizhou Foryou Medical
Instruments Co Ltd
Kangji Medical Instruments
Kangsheng Medical
Klas Medikal
Microline Surgical
Nanfang Medical
Nanjing Goldlandsw
Ningbo Bosheng Medical
Panther Healthcare
Purple Surgical
Qingdao Sinoland International Trade Co. Ltd
Reach Surgical
Shandong Weigao Group
Shanghai Divine Medical Technology
Shanghai Pharmaceutical
Shanghai Pine & Power Biotech
Shanghai RAAS
Shaoxing Zhende
Taizhou Jingwei Medical Instruments Co. Ltd
Taizhou Roosin Medical Co. Ltd.
Teleflex Medical
Top (Meiyi) Medical
Topwin (Hubei) Medical
Wego (Foosin) Sutures
Winner Medical Instruments Co. Ltd
WuHan VSD Medical
Zhejiang Kanglidi Medical Articles Co. Ltd

*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers